Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence

Annals of Neurology

Volumn 71, Issue 5, 2012, Pages 709-718

  Marnane, Michael ^a   Merwick, Aine ^a   Sheehan, Orla C ^a   Hannon, Niamh ^a   Foran, Paul ^a   Grant, Tim ^b   Dolan, Eamon ^c   Moroney, Joan ^d   Murphy, Sean ^a   O'Rourke, Killian ^a   O'Malley, Kevin ^a   O'Donohoe, Martin ^a   McDonnell, Ciaran ^a   Noone, Imelda ^e   Barry, Mary ^e   Crowe, Morgan ^e   Kavanagh, Eoin ^a   O'Connell, Martin ^a   Kelly, Peter J ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c Royal College of Surgeons in Ireland   (Ireland)

^d BEAUMONT HOSPITAL   (Ireland)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; LIFE TABLE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENCE RISK; RETINA BLOOD VESSEL OCCLUSION; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; CAROTID STENOSIS; EARLY DIAGNOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFLAMMATION; MALE; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; RECURRENCE; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84860216687     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23553     Document Type: Article

References (33)

1. Lovett JK, Coull AJ, Rothwell PM,. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62; 569-573.
2. Sheehan OC, Kyne L, Kelly LA, et al. A population-based study of ABCD2 score, carotid stenosis, and atrial fibrillation for early stroke prediction after TIA: the North Dublin TIA Study. Stroke 2010; 41: 844-845.
3. North American Symptomatic Carotid Endarterectomy Trialist's Collaborative Group. The final results of the NASCET trial. N Engl J Med 1998; 339: 1415-1425.
4. European Carotid Surgery Trialists' Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-1387.
5. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Carotid Endarterectomy Trialists' Collaboration. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-116.
6. Libby P,. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
7. Virmani R, Ladich ER, Burke AP, Kolodgie FD,. Histopathology of carotid atherosclerotic disease. Neurosurgery 2006; 59: S219-S227.
8. Ogawa M, Ishino S, Mukai T, et al. (18) F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004; 45: 1245-1250.
9. Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-2711.
10. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006; 48: 1818-1824.
11. Graebe M, Pedersen SF, Borgwardt L, et al. Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg 2009; 37: 714-721.
12. Pedersen SF, Graebe M, Fisker Hag AM, et al. Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun 2010; 31: 423-429.
13. Rudd JH, Myers KS, Bansilal S, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009; 2: 107-115.
14. Moustafa RR, Izquierdo-Garcia D, Fryer TD, et al. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke: a pilot study. Circ Cardiovasc Imaging 2010; 3: 536-541.
15. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006; 48: 1825-1831.
16. Lee SJ, On YK, Lee EJ, et al. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med 2008; 49: 1277-1282.
17. Ois A, Cuadrado-Godia E, Rodríguez-Campello A, et al. High risk of early neurological recurrence in symptomatic carotid stenosis. Stroke 2009; 40: 2727-2731.
18. Izquierdo-Garcia D, Davies JR, Graves MJ, et al. Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods. Stroke 2009; 40: 86-93.
19. Ay H, Furie KL, Singhal A, et al. An evidence-based causative classification system for acute ischaemic stroke. Ann Neurol 2005; 58: 688-697.
20. The European Stroke Organization (ESO) Executive Committee and the ESO Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
21. Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients with Extracranial Carotid and Vertebral Artery Disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Neurointerventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2011; 57: 1002-1044.
22. Font MA, Fernandez A, Carvajal A, et al. Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Front Biosci 2009; 14: 3352-3360.
23. Kelly PJ, Hedley-Whyte ET, Primavera J, et al. Diffusion MRI in ischemic stroke compared to pathologically verified infarction. Neurology 2001; 56: 914-920.
24. Kwee RM, Truijman MT, Mess WH, et al. Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques. AJNR Am J Neuroradiol 2011; 32: 950-954.
25. Paulmier B, Duet M, Khayat R, et al. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 2008; 15: 209-217.
26. Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 2009; 50: 1611-1620.
27. Grandpierre S, Desandes E, Meneroux B, et al. Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case-control pilot study. Clin Nucl Med 2011; 36: 85-90.
28. Arauz A, Hoyos L, Zenteno M, et al. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 2007; 109: 409-412.
29. Wu YW, Kao HL, Chen MF, et al. Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med 2007; 48: 227-233.
30. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and the timing of surgery. Lancet 2004; 363: 915-924.
31. Hsia AW, Kidwell CS,. Magnetic resonance imaging for surrogate outcomes and patient selection. Front Neurol Neurosci 2009; 25: 189-192.
32. Markus HS, Droste DW, Kaps M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111: 2233-2240.
33. Rudd JH, Narula J, Strauss HW, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for primetime? J Am Coll Cardiol 2010; 55: 2527-2535.